Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1989 Nov;73(11):895–899. doi: 10.1136/bjo.73.11.895

A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

L L Hansen 1, J Wiek 1, M Wiederholt 1
PMCID: PMC1041922  PMID: 2690927

Abstract

In a randomised study 25 patients over 50 years of age with non-ischaemic central retinal vein occlusion (CRVO) were assigned to either a treatment (14 patients, isovolaemic haemodilution) or a control group (11 patients, no treatment). After three months eight eyes in patients with haemodilution improved, whereas none of the untreated eyes had better visual acuity (p less than 0.01). Thirteen haemodiluted and 11 control patients could be observed for one year. Six eyes of the haemodiluted patients retained a better visual acuity, whereas no improvements had occurred in the control group (p less than 0.025). In fluorescein angiography the lowering of the packed cell volume to 35-32% accelerated the time of maximal venous filling (tmvf) from 17.4 (SEM 1.4) s to 11.4 (SEM 0.9) s (p less than 0.005). In patients with non-ischaemic CRVO without treatment the passage time did not change. The shortened tmvf reflects a higher blood velocity. Thus isovolaemic haemodilution improves the visual prognosis in non-ischaemic CRVO probably by inducing a higher blood fluidity, which results in higher blood velocity, at least in areas of compromised retinal microcirculation.

Full text

PDF
895

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hayreh S. S. Classification of central retinal vein occlusion. Ophthalmology. 1983 May;90(5):458–474. doi: 10.1016/s0161-6420(83)34530-9. [DOI] [PubMed] [Google Scholar]
  2. Hayreh S. S. So-called "central retinal vein occlusion". I. Pathogenesis, terminology, clinical features. Ophthalmologica. 1976;172(1):1–13. doi: 10.1159/000307579. [DOI] [PubMed] [Google Scholar]
  3. Hayreh S. S. So-called "central retinal vein occlusion". II. Venous stasis retinopathy. Ophthalmologica. 1976;172(1):14–37. doi: 10.1159/000307580. [DOI] [PubMed] [Google Scholar]
  4. Hedin H., Richter W., Ring J. Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Int Arch Allergy Appl Immunol. 1976;52(1-4):145–159. doi: 10.1159/000231676. [DOI] [PubMed] [Google Scholar]
  5. Laatikainen L., Kohner E. M. Fluorescein angiography and its prognostic significance in central retinal vein occlusion. Br J Ophthalmol. 1976 Jun;60(6):411–418. doi: 10.1136/bjo.60.6.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Laatikainen L., Kohner E. M., Khoury D., Blach R. K. Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study. Br J Ophthalmol. 1977 Dec;61(12):741–753. doi: 10.1136/bjo.61.12.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McGrath M. A., Wechsler F., Hunyor A. B., Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med. 1978 Feb;138(2):216–220. [PubMed] [Google Scholar]
  8. Ring C. P., Pearson T. C., Sanders M. D., Wetherley-Mein G. Viscosity and retinal vein thrombosis. Br J Ophthalmol. 1976 Jun;60(6):397–410. doi: 10.1136/bjo.60.6.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sinclair S. H., Gragoudas E. S. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol. 1979 Nov;63(11):735–743. doi: 10.1136/bjo.63.11.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Welch J. C., Augsburger J. J. Assessment of angiographic retinal capillary nonperfusion in central retinal vein occlusion. Am J Ophthalmol. 1987 Jun 15;103(6):761–766. doi: 10.1016/s0002-9394(14)74390-9. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES